Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,993.49
(
0.48%
)
News Focus
News Focus

Replies to post #521726 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #521726 on NorthWest Biotherapeutics Inc (NWBO)
icon url

HyGro

10/14/22 2:20 PM

#521904 RE: Roman516 #521726

Regulators cared about Optune Phase 3 trial -- They all approved it and Optune is generating revenue.

Investment community isn't showing optimism for NWBO approval as the share price showed NO positive response to the TLD data.